Annaliesse Blincoe

692 total citations
7 papers, 165 citations indexed

About

Annaliesse Blincoe is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Annaliesse Blincoe has authored 7 papers receiving a total of 165 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Immunology, 3 papers in Hematology and 3 papers in Genetics. Recurrent topics in Annaliesse Blincoe's work include Immunodeficiency and Autoimmune Disorders (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Annaliesse Blincoe is often cited by papers focused on Immunodeficiency and Autoimmune Disorders (3 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). Annaliesse Blincoe collaborates with scholars based in Canada, United States and New Zealand. Annaliesse Blincoe's co-authors include H. Bobby Gaspar, Donald B. Kohn, Alessandro Aiuti, Jennifer M. Puck, Michael S. Hershfield, Luigi D. Notarangelo, Eyal Grunebaum, Élie Haddad, Julie Barsalou and Roxane Labrosse and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and Journal of Immunological Methods.

In The Last Decade

Annaliesse Blincoe

6 papers receiving 163 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Annaliesse Blincoe Canada 5 94 71 56 29 24 7 165
João Farela Neves Portugal 9 131 1.4× 44 0.6× 44 0.8× 34 1.2× 21 0.9× 24 222
Bella Shadur Australia 10 97 1.0× 49 0.7× 65 1.2× 57 2.0× 24 1.0× 20 214
Lisa Forbes Satter United States 7 102 1.1× 43 0.6× 32 0.6× 21 0.7× 15 0.6× 16 164
Enrica Calzoni Italy 4 163 1.7× 87 1.2× 30 0.5× 49 1.7× 19 0.8× 5 214
Samaneh Delavari Iran 9 110 1.2× 48 0.7× 53 0.9× 16 0.6× 22 0.9× 37 191
Peter Mustillo United States 5 127 1.4× 62 0.9× 49 0.9× 11 0.4× 20 0.8× 18 184
Joris van Montfrans Netherlands 10 203 2.2× 75 1.1× 66 1.2× 30 1.0× 30 1.3× 13 291
Funda Çipe Türkiye 9 114 1.2× 66 0.9× 33 0.6× 36 1.2× 13 0.5× 34 238
Jahnavi Aluri India 10 198 2.1× 58 0.8× 39 0.7× 22 0.8× 19 0.8× 15 267
Nesrine Radwan Egypt 6 95 1.0× 48 0.7× 51 0.9× 11 0.4× 12 0.5× 17 165

Countries citing papers authored by Annaliesse Blincoe

Since Specialization
Citations

This map shows the geographic impact of Annaliesse Blincoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annaliesse Blincoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annaliesse Blincoe more than expected).

Fields of papers citing papers by Annaliesse Blincoe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annaliesse Blincoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annaliesse Blincoe. The network helps show where Annaliesse Blincoe may publish in the future.

Co-authorship network of co-authors of Annaliesse Blincoe

This figure shows the co-authorship network connecting the top 25 collaborators of Annaliesse Blincoe. A scholar is included among the top collaborators of Annaliesse Blincoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annaliesse Blincoe. Annaliesse Blincoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Blincoe, Annaliesse, Pierre Teira, Henrique Bittencourt, et al.. (2023). Case report: Success of allogeneic hematopoietic stem cell transplantation for refractory systemic-onset juvenile idiopathic arthritis. Frontiers in Medicine. 10. 1275927–1275927.
2.
Blincoe, Annaliesse, Roxane Labrosse, & Roshini S. Abraham. (2022). Acquired B-cell deficiency secondary to B-cell-depleting therapies. Journal of Immunological Methods. 511. 113385–113385. 6 indexed citations
3.
Labrosse, Roxane, Sara Barmettler, Beáta Dérfalvi, et al.. (2021). Rituximab-induced hypogammaglobulinemia and infection risk in pediatric patients. Journal of Allergy and Clinical Immunology. 148(2). 523–532.e8. 33 indexed citations
4.
Kohn, Donald B., Michael S. Hershfield, Jennifer M. Puck, et al.. (2018). Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency. Journal of Allergy and Clinical Immunology. 143(3). 852–863. 81 indexed citations
5.
Barsalou, Julie, Annaliesse Blincoe, Isabel Fernández, et al.. (2018). Rapamycin as an Adjunctive Therapy for NLRC4 Associated Macrophage Activation Syndrome. Frontiers in Immunology. 9. 2162–2162. 27 indexed citations
6.
Labrosse, Roxane, Annaliesse Blincoe, Guilhem Cros, et al.. (2017). Very Early-Onset Inflammatory Manifestations of X-Linked Chronic Granulomatous Disease. Frontiers in Immunology. 8. 1167–1167. 15 indexed citations
7.
Preece, Kahn, et al.. (2016). Paediatric non-IgE mediated food allergy: guide for practitioners.. PubMed. 129(1430). 78–88. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026